BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1527815)

  • 1. Role of circulating immune-complexes as prognostic indicators of lympho-reticular and mesenchymal malignancies in children.
    Aziz M; Dass TK; Rattan A
    J Trop Pediatr; 1992 Aug; 38(4):185-8. PubMed ID: 1527815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of circulating immune complexes in malignant tumours of head and neck.
    Das TK; Aziz M; Rattan A; Sherwani R
    J Indian Med Assoc; 1995 Jan; 93(1):3-7. PubMed ID: 7759908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of cell-mediated immunity and circulating immune complexes as prognostic indicators in cancer patients.
    Aziz M; Akhtar S; Malik A
    Cancer Detect Prev; 1998; 22(2):87-99. PubMed ID: 9544429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of circulating immune complexes in prognostic evaluation and management of genitourinary cancer patients.
    Aziz M; Das TK; Rattan A
    Indian J Cancer; 1997 Sep; 34(3):111-20. PubMed ID: 9491672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of circulating immune complexes in cancer patients.
    Dass TK; Aziz M; Rattan A
    Jpn J Cancer Res; 1991 Nov; 82(11):1284-91. PubMed ID: 1752784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility and monitoring of breast cancer by circulating immune complexes.
    Dass TK; Aziz M; Rattan A; Tyagi SP
    Indian J Pathol Microbiol; 1992 Oct; 35(4):298-307. PubMed ID: 1344219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating immune complexes in advanced Hodgkin's disease: qualitative analysis and prognostic significance.
    Tomasević Z; Jelić S
    Arch Immunol Ther Exp (Warsz); 2000; 48(3):195-200. PubMed ID: 10912625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Circulating immune complexes of patients with malignant lymphomas (author's transl)].
    Sodomann CP; Schmidt H; Havemann K
    Blut; 1979 Jun; 38(6):435-46. PubMed ID: 444682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Circulating immune complexes in the serum in Hodgkin's disease].
    Nikolić V; Zivanović L; Banićević B; Milosević-Jovcić N
    Bilt Hematol Transfuz; 1980; 8(1):19-27. PubMed ID: 7337679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating immune complexes in Hodgkin's disease.
    Brown CA; Hall CL; Long JC; Carey K; Weitzman SA; Aisenberg AC
    Am J Med; 1978 Feb; 64(2):289-94. PubMed ID: 629278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating immune complexes in Hodgkin's disease.
    Akolkar PN; Advani SH; Gothoskar BP
    Neoplasma; 1983; 30(1):73-9. PubMed ID: 6835441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of circulating immune complexes in pulmonary tuberculosis.
    Samuel AM; Ashtekar MD; Ganatra RD
    Clin Exp Immunol; 1984 Nov; 58(2):317-24. PubMed ID: 6437714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating immune complexes and prognosis in human malignant lymphoma, a prospective study.
    Heier HE; Landaas TO; Marton PF
    Int J Cancer; 1979 Mar; 23(3):292-8. PubMed ID: 437911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating immune complexes (CIC) in Hodgkin's disease. I. Levels and two-dimensional analysis.
    Nerurkar AV; Advani SH; Gothoskar BP
    Neoplasma; 1989; 36(2):199-205. PubMed ID: 2716924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of splenectomy on the levels of circulating immune complexes (CIC) in Hodgkin's disease (HD).
    Nerurkar AV; Advani SH; Gothoskar BP
    Neoplasma; 1987; 34(1):89-93. PubMed ID: 3561608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating immune complexes in Hodgkin's disease. Reactivity of IgG isolated from circulating immune complexes.
    Nerurkar AV; Advani SH; Gothoskar BP
    Neoplasma; 1993; 40(2):87-91. PubMed ID: 8350960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating immune complexes and serum lysozyme levels in untreated Hodgkin's disease. Their relationship to immune function.
    Spinozzi F; Velardi A; Rambotti P; Losito A; Zampi I; Cernetti C; Gerli R; Martelli MF; Grignani F
    J Clin Lab Immunol; 1983 Oct; 12(2):87-92. PubMed ID: 6644793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement-mediated immune complex solubilization and precipitation inhibition in sera of patients with non-Hodgkin's lymphoma.
    Bányai A; Pálóczi K; Csipö I; Csongor J; Szegedi G
    Haematologia (Budap); 1990; 23(2):87-95. PubMed ID: 2272539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating immune complexes of Hodgkin's disease contain an antigen that is present in Hodgkin and Reed-Sternberg cells.
    Bepler G; Zhen QY; Havemann K
    J Cancer Res Clin Oncol; 1985; 110(1):56-64. PubMed ID: 2410427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of circulating immune complexes in leprosy.
    Ramos GS; Bottasso OA; Morini JC; Segal-Eiras A
    Rev Argent Microbiol; 1988; 20(4):163-70. PubMed ID: 3247413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.